Financials

  • Market Capitalization 45.73 M
  • Employee 115
  • Founded 1998
  • CEO N/A
  • Website www.celularity.com
  • Headquarter Delaware, United States
  • FIGI BBG00P2RTT34
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.31
Price to sales ratio
1.07

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4259
MCRB
Seres Therapeutics, Inc. - Common Stock
5.11 USD+3.23%+13.30%+7.13%-37.91%50.80 M USD
4281
TCRX
TScan Therapeutics, Inc. - Common Stock
0.75 USD0.00%-5.06%-1.32%-58.33%47.63 M USD
4292
HOWL
Werewolf Therapeutics, Inc. - Common Stock
0.94 USD-3.09%+10.59%+108.89%-27.69%45.68 M USD
4295
MGX
Metagenomi Therapeutics, Inc. - Common Stock
1.19 USD-1.65%-4.80%-0.83%-17.36%44.95 M USD

Frequently asked questions about Celularity Inc. Class A Common Stock

What is the Celularity Inc. Class A Common Stock stock price today?

The current price of Celularity Inc. Class A Common Stock (CELU) is 1.58. Over the past 24 hours, the stock has changed by -24.76%. Follow the CELU chart for real-time price dynamics.

What is the stock ticker of Celularity Inc. Class A Common Stock?

Celularity Inc. Class A Common Stock trades under the ticker CELU. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Celularity Inc. Class A Common Stock stock going up?

CELU has changed by +105.19% over the last week, +132.35% over the last month, and -49.03% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Celularity Inc. Class A Common Stock?

Celularity Inc. Class A Common Stock currently has a market capitalization of 45.73 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Celularity Inc. Class A Common Stock earnings last quarter?

Last quarter, Celularity Inc. Class A Common Stock reported earnings of -0.85 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Celularity Inc. Class A Common Stock revenue for the last quarter?

Celularity Inc. Class A Common Stock reported quarterly revenue of 4.1 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Celularity Inc. Class A Common Stock net income for the last quarter?

Celularity Inc. Class A Common Stock reported net income of -24.36 M for the last quarter. The previous quarter showed -23.08 M, which means net income changed by -5.57%.

How many employees does Celularity Inc. Class A Common Stock have?

As of the latest available data, Celularity Inc. Class A Common Stock has 115 employees. Workforce size can provide additional context about the company's scale and operations.

What is Celularity Inc. Class A Common Stock EBITDA?

Celularity Inc. Class A Common Stock EBITDA is -23.25 M, and its EBITDA margin is -566.54%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Celularity Inc. Class A Common Stock stock?

You can buy Celularity Inc. Class A Common Stock (CELU) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Celularity Inc. Class A Common Stock stock?

Investing in Celularity Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CELU chart and related analysis on metatrader.com as part of your research.

News